InvVax Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 7

InvVax General Information

Description

Developer of a universal influenza vaccine designed to provide broad and lasting protection against all flu strains. The company targets invariant regions of the flu virus genome to prevent pandemics by enhancing immune responses to viral diseases, enabling global populations to benefit from a vaccine that prevents viral mutation and reduces the risk of seasonal mismatches.

Contact Information

Website
www.inv-vax.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 370 Amapola Avenue
  • Suite 100
  • Torrance, CA 90501
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 370 Amapola Avenue
  • Suite 100
  • Torrance, CA 90501
  • United States

InvVax Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

InvVax Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Secondary Transaction - Private 01-Jan-2025 Completed Generating Revenue
11. Accelerator/Incubator 01-Jan-2025 Completed Generating Revenue
10. Equity Crowdfunding 01-Apr-2024 Completed Generating Revenue
9. Accelerator/Incubator 01-Mar-2022 Completed Generating Revenue
8. Later Stage VC 01-Jan-2021 Completed Generating Revenue
7. Later Stage VC 01-Sep-2019 Completed Generating Revenue
6. Later Stage VC 27-Nov-2018 Completed Generating Revenue
5. Later Stage VC 01-Jan-2018 Completed Generating Revenue
4. Accelerator/Incubator 01-Jan-2017 $375K Completed Generating Revenue
3. Later Stage VC 01-Jan-2017 $375K Completed Generating Revenue
To view InvVax’s complete valuation and funding history, request access »

InvVax Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed-3
Seed-2
Seed 1,136,268 $0.000100 6% $0.39 $0.39 1x $0.39 12.49%
To view InvVax’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

InvVax Patents

InvVax Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2017386682-A1 Influenza vaccines Inactive 28-Dec-2016
CA-3048448-A1 Influenza vaccines Inactive 28-Dec-2016
EP-3562498-A1 Influenza vaccines Inactive 28-Dec-2016
EP-3562498-A4 Influenza vaccines Inactive 28-Dec-2016
US-11111277-B2 Influenza vaccines Active 28-Dec-2016 C07K14/005
To view InvVax’s complete patent history, request access »

InvVax Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

InvVax Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Pasadena Bio Accelerator/Incubator
Angel (individual) Minority
US National Science Foundation Accelerator/Incubator
Evolution VC Partners Venture Capital Minority
Seeds San Diego Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

InvVax FAQs

  • When was InvVax founded?

    InvVax was founded in 2012.

  • Where is InvVax headquartered?

    InvVax is headquartered in Torrance, CA.

  • What is the size of InvVax?

    InvVax has 4 total employees.

  • What industry is InvVax in?

    InvVax’s primary industry is Drug Discovery.

  • Is InvVax a private or public company?

    InvVax is a Private company.

  • What is InvVax’s current revenue?

    The current revenue for InvVax is .

  • How much funding has InvVax raised over time?

    InvVax has raised $2.5M.

  • Who are InvVax’s investors?

    Pasadena Bio, , US National Science Foundation, Evolution VC Partners, and Seeds San Diego are 5 of 7 investors who have invested in InvVax.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process